Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights.

Sorry, there's nothing here.

Cite this paper

@article{Stewart2017AdjuvantPD, title={Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights.}, author={Grant Duncan Stewart and Bradley C. Leibovich and Sylvie N{\'e}grier and Robert Alan Figlin}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2017}, pages={JCO2017754242} }